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Abstract
Background: Medicinal herb-derived drug development has become important in the relief of liver pathology.
Amomun cardamomum is traditionally used therapeutically in Korea to treat various human ailments including
dyspepsia, hiccupping, and vomiting. We investigated to assess the protective effect of A. cardamomum on carbon
tetrachloride (CCl4)-induced liver damage through antioxidant activity in hepatic tissues of Sprague–Dawley rats.
Methods: Antioxidant properties of different fractions from A. cardamomum from ethanol extracts were evaluated
by an in vitro free radical scavenging systems. The protective effect of the ethyl acetate fraction from A.
cardamomum (EAAC) against CCl4-induced cytotoxicity was determined by a cell viability assay using HepG2
hepatocarcinoma cells. In vivo study, the influence of EAAC concentrations of 100 and 200 mg/kg following
CCl4-induced hepatic injury was assessed. Serum levels of glutamic oxaloacetic transaminase (GOT), glutamic
pyruvic transaminase (GPT), and alkaline phosphatase (ALP) were determined, as was lipid peroxidation
(malondialdehyde, MDA). Effect of EAAC on liver detoxification enzymes including superoxide dismutase (SOD),
total glutathione (GSH), and glutathione S-transferase (GST) activity was measured in rat liver homogenates. Liver
cytochrome P450 (CYP2E1) expression level was determined by quantification of mRNA.
Results: Phytochemical analysis of A. cardamomum indicated that EAAC was enriched in total polyphenol and total
flavonoid. Most of the tannins were confined to the hexane fraction. Hepatoprotective properties of EAAC were
evident, with significantly reduced serum levels of GOT, GPT, and ALP compared with the control group. Improved
hepatic antioxidant status was evident by increased SOD, GSH, and GST enzymes in rat liver tissue. Liver lipid
peroxidation induced by CCl4 was apparent by increased intracellular MDA level. EAAC suppressed lipid
peroxidation as evidenced by the significant decrease in MDA production. Expression of CYP2E1 was also
significantly decreased at the higher concentration of EAAC, indicating the hepatoprotective efficacy of EAAC on
acute liver damage.
Conclusion: These results indicated that EAAC has a significant hepatoprotective activity on CCl4-induced acute
hepatic injury in rats, which might be derived from its antioxidant properties and CYP2E1 downregulation.
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Background
The liver is crucial in metabolizing xenobiotics through
various mechanisms that involve numerous detoxifica-
tion enzymes and antioxidant activity. Accordingly, the
liver is continuously exposed to harmful oxidative
stresses that impair cell function, which trigger several
liver diseases [1, 2]. Liver diseases remained a major glo-
bal health burdens and medical issue [3]. Oxidative
stress is defined as an imbalance between the systemic
manifestation of reactive oxygen species (ROS) and the
antioxidant defenses [4]. Oxidative stress is crucial in the
pathogenesis of liver diseases including fibrosis and liver
cirrhosis [5–9]. ROS are chemically reactive molecules
containing oxygen that normally function in cellular re-
sponses in signal transduction to sustain life and as part
of host defenses against various infections [10]. However,
excessive production of free radicals including super-
oxide, hydroxyl radical, lipid free radical, and nitric oxide
leads to damage in certain diseases of the liver [11]. In-
hibition of free radicals has been linked to the alleviation
of liver disorders [12].
Carbon tetrachloride (CCl4) can induce free radical
toxicity and has been used as a hepatotoxin in diverse
liver disease models [13, 14]. CCl4 is converted into re-
actants through the formation of reactive intermediates
including trichloromethyl radicals (CCl3·, CCl3OO·) and
free radicals by cytochrome P450 (CYP 450) [15]. These
free radicals and related oxidative stresses induce the de-
formation of cellular macromolecules, and increases
lipid peroxidation, protein degeneration, and genomic
mutations in human liver tissue [16]. A member of the
CYP family, CYP2E1, is involved in these reactions and
in the metabolism of xenobiotics like ethanol. CYP2E1 is
regulated by endogenous factors and foreign compounds
[17, 18]. Suppression of CYP2E1 has reduced liver dam-
age in various experimental models including in vitro
and in vivo systems [19–21].
The side effects of modern synthetic drugs used to
treat liver diseases remains unclear. Traditional medi-
cines and plant-derived drugs might be an attractive al-
ternative in the prevention and treatment of hepatic
disorders [12, 22]. Amomum cardamomum L., a member
of Zingiberaceae family, can be distinguished from large
cardamom native to southern India and is nowadays cul-
tivated widely in tropical regions. The plant seeds are
widely used as a spice in many countries and tradition-
ally as a therapeutic for relief of dyspepsia, hiccupping,
vomiting, and alcohol detoxification [23]. The previous
studies have reported that seed of A. cardamomum and
its active components had antioxidant and anti-
inflammatory activities [24, 25]. Important essential oils
constituents including terpenes have been reported in
this plant [26]. Another reports suggest that essential
oils treatment containing α, β-pinene, d-camphor, and
1,8-cineole inhibited liver injury in animal models [27–
29]. 1,8-Cineole, the bicyclic monoterpene rich in A. car-
damomum has been reported to have protective
bioactivity on liver against steatosis, and 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD) in vivo [30, 31]. An-
other study revealed relation between antioxidant
activity and hepatoprotection [32, 33] which suggests
potential effect of A. cardamomum on the liver disease
related to free radical and other ROS production. The
effects of A. cardamomum and its fractions on attenuat-
ing CCl4-induced hepatotoxicity are unknown, with no
study of the involvement of antioxidant activity in vitro
and in vivo.
Therefore, in this study we evaluated the possible anti-
oxidant properties and hepatoprotective effects of the
ethyl acetate fraction obtained from A. cardamomum
(EAAC) against CCl4-induced hepatic injury in vitro and
in vivo. Furthermore, CYP2E1 gene expression level was
investigated to demonstrate the downregulating activity
of the EAAC; results were compared to the effects of




2.2-Diphenyl-1-picryl hydrazyl (DPPH), butylated hy-
droxytoluene (BHT), d(+)-catechin, gallic acid, tannic
acid, sodium carbonate, nitrobluetetrazolium (NBT),
xanthine, xanthine oxidase, and Folin-Ciocalteu reagent,
iron(III) chloride (FeCl3), hydrogen peroxide (H2O2),
ascorbic acid were all purchased from Sigma-Aldrich
(St. Louis, MO, USA) or Merck & Co (Darmstadt,
Germany). For in vitro studies, bovine serum albumin,
Dulbecco’s Modified Eagle Medium (DMEM), fetal bo-
vine serum (FBS), Dulbecco’s phosphate buffered saline
(DPBS), penicillin, and streptomycin were purchased
from Hyclone (Logan, UT, USA). Oligo primers were
purchased from Macrogen (Seoul, Korea). For in vivo
studies, silymarin, olive oil, CCl4, Oil Red O,
hematoxylin and eosin (H&E) stain, triethanolamide,
5,5’-dithiobis(2-nitrobenzoic acid) (DTNB), glutathione
(GSH), superoxide dismutase (SOD), 2-thiobarbituric
acid (TBA), and sodium azide were purchased from
Sigma-Aldrich.
A. cardamomum and extraction
Dried A. cardamomum seeds were purchased from
Dongwoodang (Yeongcheon-si, Korea). The seeds were
ground finely using a mixer grinder and the resulting
powder was extracted by a 3-day immersion in 70 %
ethanol. The extract was evaporated using a rotary evap-
orator (Büchi, Flawil, Switzerland) prior to sequential
fractionation using hexane, dichloromethane, and ethyl
acetate applied with an extraction funnel. Each fraction
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was concentrated and dried using the aforementioned
rotary evaporator. The extract was harvested and used
as samples.
Cell culture and viability assay
HepG2 human liver carcinoma cells were cultured in
DMEM supplemented with 10 % FBS, 100 U/ml penicil-
lin and streptomycin. Cells were incubated at 37 °C in a
humidified environment containing 5 % CO2. Cells were
subcultured at 70-80 % confluence and seeded at a dens-
ity of 1 × 105 cells/well in 96-well plates. After 24 h, the
medium changed to FBS-free DMEM. After 24 h pre-
treatment of EAAC samples (dissolved in DMSO), the
medium was changed to DMEM containing 8 mM CCl4.
The cells were incubated in 37 °C in the humidified CO2
incubator for 2 h followed by cell viability determined
using the EZ-Cytox cell viability assay kit (Daeil Lab Ser-
vice, Seoul, Korea) as described by the manufacturer.
Briefly, 10 μl of the EZ-Cytox reagent was added to each
culture well of a 96-well microplate and incubated at
37 °C in the humidified CO2 incubator for 2 h. After in-
cubation, optical density (OD) of the supernatant was
measured at a wavelength of 450 nm using a microplate
reader.
Determination of total phenolic, flavonoids and tannins
Tannin content
Tannin content was measured using the Folin-Denis
method [34]. Fifty microliters of extract was made up to
7.5 ml by the addition of distilled water. Then, 0.5 ml of
Folin Denis reagent and 1 ml of Na2CO3 were added
and mixed. The volume was made up to 10 ml using dis-
tilled water. The absorption was recorded at 700 nm.
Tannic acid and distilled water was used as standard and
blank, respectively.
Phenol content
Phenol content was measured by the Folin-Ciocalteu
method [35]. A sample aliquot 40 μl was added to
200 μl of Folin-Ciocalteu reagent along with 1160 μl of
distilled water and mixed. The mixture was incubated
for 3 min at room temperature prior to the addition of
600 μl of 2 % sodium carbonate. After 2 h incubation in
the dark, the mixture was aliquoted into wells of a 96
well plate and the OD was measured at 765 nm. Gallic
acid and distilled water was used as standard and blank,
respectively.
Flavonoid content
Total flavonoid content for samples was determined by
the aluminium chloride colorimetric method [36] with
slight modification. 1 ml of water was added to 250 μl
samples in a tube. At zero time, 75 μl of 5 % NaNO2
was added to the tube. After 5 min, 0.3 ml of 10 % AlCl3
was added and incubated for 6 min. After, 0.5 ml of 1 M
NaOH was added to the mixture. Absorbance was read
at 510 nm with water as the blank. Various concentra-
tions of (+) catechin hydrate solution was used as
standard.
In vitro antioxidant properties
To determine free radical scavenging activities of sample,
40 μl of various concentrations of sample was added to
760 μl solution of 0.3 mM DPPH dissolved in ethanol.
An equal amount of ethanol and DPPH served as con-
trol. After 30 min incubation in the dark, the absorbance
was recorded at 517 nm. The experiment was performed
in triplicate and the activity was presented as percentage
of scavenged radical. To determine superoxide anion
scavenging activities of sample a slight modification of a
prior protocol was used [37]. In brief, each sample was
mixed with 30 mM EDTA (pH 7.4), 3 mM hypoxanthine
in 50 mM sodium peroxide, and 1.42 mM NBT. The
mixture was incubated for 3 min at room temperature
following the addition of xanthine oxidase and increased
volume to to 3 ml with phosphate buffer (pH 7.4). The
mixture was incubated for 20 min at room temperature
and absorbance at 560 nm was measured using a spec-
trophotometer. To determine hydroxyl radical scaven-
ging activity, cloned pBR322 plasmid DNA from
transformed bacteria was used in assay. Supercoiled (SC)
pBR322 plasmid DNA (2.0 μg) was mixed with various
concentrations of EAAC. The fenton’s reagent (80 μM
FeCl3, 0.3 mM H2O2, 50 μM ascorbic acid) was added to
samples and volume brought up to 20 μl. The mixture
was incubated at 37 °C for 30 min. Samples were loaded
into agarose gel and photographed under UV illuminator.
Animals and experimental design
Six-week-old specific pathogen-free male Sprague–Daw-
ley rats (n = 30) purchased from Koatech (Gyeonggi-do,
Korea) received standard normal diet and water ad libi-
tum. The animals were acclimatized to 12 h light/dark
cycles for 7 days prior to the experiments. They were di-
vided randomly into five groups of six rats: negative con-
trol (olive oil; 1 ml/kg), CCl4 (1 ml/kg, dissolved 1:1 in
olive oil), CCl4 + Silymarin (50 mg/kg, dissolved in olive
oil), CCl4 + low dose EAAC (100 mg/kg, dissolved in
olive oil), and CCl4 + high dose EAAC (200 mg/kg, dis-
solved in olive oil). All treatments were administrated
every 72 h for 5 weeks. Bodyweight was recorded
weekly. The day after the final treatment, all animals
were starved overnight and sacrificed. Whole blood was
collected from the abdominal aorta and the liver was
harvested under zoletil anesthesia. All protocols for ani-
mal experiments were approved by the ethics committee
of Dongguk University (No. 2014–09110).
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Serum biochemistry
After sacrifice, the collected blood was immediately cen-
trifuged at 3000 rpm for 20 min. The supernatant was
stored at 4 °C until analyses for alanine transaminase
(ALT), aspartate transaminase (AST), and alkaline phos-
phatase (ALP) using commercial kits (Company, Asan,
Korea) according to the manufacture’s protocols. As
well, OD was determined using a spectrophotometer.
Determination of lipid peroxidation
Lipid peroxidation level of rat liver was assessed by a
previously described malondialdehyde (MDA) assay
protocol [38] with slight modification. In brief, rats were
sacrificed and the liver was isolated after blood perfu-
sion. Liver tissue was homogenized with 1.15 % KCl (9:1,
w/w). Aliquots (400 μl) of homogenate were mixed with
TBA to a final concentration of 8.1 %. The reactant was
heated to 95 °C for 1 h prior to the addition of 1 ml of
distilled water and a 5 ml solution of n-butanol and pyri-
dine (15:1). The reactant was centrifuged at 3000 rpm
for 30 min. The supernatant was transferred to wells of
a 96-well plate and the OD was measured at 532 nm.
Various concentrations of 1,1,3,3-tetraethoxy propane
were used as standard.
Intracellular antioxidant enzymes detection
Total Sulfhydryl (SH) level of liver tissue was measured
using a prior protocol [39]. In brief, 20 μl of liver sample
or standard was mixed with 75 μl of Tris–HCl (pH 8.2)
and 25 μl of DTNB (3 mM) in methanol prior to the
addition of 400 μl of methanol. Then mixture was spin
down at 3000 g for 5 min at room temperature. The
sample was transferred to well of a microplate and ab-
sorbance was read at 412 nm. Different concentrations
of GSH were used as standard. The experiments were
conducted in triplicate. SOD activity of liver tissue was
investigated using NBT [40]. Briefly, 0.1 mM xanthine,
0.1 mM EDTA, and 25 uM NBT were dissolved in 60
uM sodium bicarbonate buffer. Sample and reaction buf-
fer was mixed in a 1:9 (w/w) ratio. SOD was used as
standard. One unit of SOD was equivalent to the
amount of enzyme that inhibited the rate of the CYP-
catalyzed reaction by 50 %.
Histology
Liver tissues were frozen using a frozen section com-
pound (Leica, Jena, Germany) and sectioned using a
model CM 1860 cryotome (Leica). Slide sections were
fixed with 10 % formaldehyde and deparaffinized and
stained with H&E or Oil Red O stain. Microscopic im-
ages were taken under 200 × concentrations using a DFC
480 microscope system (Leica).
Quantitative real-time polymerase chain reaction (RT-PCR)
and conventional PCR
A portion of each liver tissue was stored in RNA Later
solution (Life Technologies, Carlsbad, CA, USA) at −80 °
C for investigation of mRNA expression. Liver mRNA
was isolated from liver tissues using Trisure (Bioline,
Taunton, MA, USA) following the manufacturer’s proto-
col. Isolated mRNA was checked for RNA integrity and
cDNA was synthesized. PCR amplification comprised
10 min at 95 °C, 45 denaturation cycles at 95 °C for 10 s,
annealing at 52 °C for 30 s, and extension at 72 °C for
15 s. This was followed by melting curve analysis. Every
Ct value and Second Derivative Max quantification was
checked. Results were analyzed using Light Cycler soft-
ware (Roche Applied Science, Basel, Switzerland).
Primer sequences used for RT-PCR were as follows: GST
sense 5’- GCCTTCTACCCGAAGACACCTT - 3’ and anti-
sense 5’ - GTCAGCCTGTTCCCTACA - 3’, SOD sense 5’ -
AGGCCGTGTGCGTGCTGAG - 3’ and antisense 5’ - CA
CCTTTGCCCAAGTCATCTGC - 3’, CYP2E1 sense 5’ - A
TGTCATCCCCAAGGGTACA - 3’ and antisense 5’ - A
GGCCTTCTCCAACACACAC - 3’, GAPDH sense 5’ - G
GCACAGTCAAGGCTGAGAATG - 3’ and GAPDH anti-
sense 5’ – ATGGTGGTGAAGACGCCAGTA - 3’.
Conventional PCR for CYP2E1 gene was conducted
with 30 amplification cycles of PCR consisting of de-
naturation at 95 °C for 1 min, annealing at 52 °C for
1.5 min, elongation at 72 °C for 2 min. Equal amount of
PCR product was then loaded and performed electro-
phoresis on 1 % agarose gel for 30 min. The relevant ex-
pression level was then visualized by UV illuminator
(UVP, Cambridge, UK).
Statistical analyses
The results are expressed as mean ± standard deviation
(SD). Experimental data were analyzed using Graph Pad
prism version 5.0 software (Graph Pad, La Jolla, CA,
USA). Standard curves were constructed using Excel and
Powerpoint software (Microsoft, Redmond, WA, USA).
All samples were compared with a standard graph using
analysis of variance and Student’s t-test. A p-value < 0.05
was considered statistically significant.
Results
Phytochemical analysis and antioxidant activity
Among the fractions obtained, EAAC displayed the
highest content of polyphenol (72.32 ± 1.22 mg GAE/g
dried extract) and flavonoid (4.03 ± 0.05 mg CE/g dried
extract). Tannins were most abundant in the hexane
fraction (86.12 ± 3.09 mg TAE/g dried extract) followed
by the ethyl acetate fraction (51.52 ± 3.32 mg TAE/g
dried extract) (Table 1).
A. cardamomum extracts were fractionated with vari-
ous solvents. EAAC showed highest efficacy in free
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radical scavenging activity and superoxide anion scaven-
ging activity (Table 1). EAAC also displayed hydroxyl
radical scavenging activity. Fenton’s reagent fragmented
plasmid DNA into small size band (Fig. 1). EAAC dis-
played a dose-dependent protective effect from hydrogen
peroxide.
HepG2 cell proliferation in CCl4-induced hepatotoxicity
There was no significant toxicity shown by EAAC treat-
ment to HepG2 cell for 24 h under 100 μg/ml concen-
tration (Fig. 2a). Changing the culture medium to CCl4
(8 mM) DMEM for 2 h reduced HepG2 cell viability by
55 % (Fig. 2b). Silymarin pretreatment successfully in-
creased viability of HepG2 cells. Furthermore, viability
of cell populations pretreated with EAAC was enhanced
upon CCl4 treatment in a dose dependent manner, with
90 % preservation of viability using 100 μg/ml EAAC.
Liver enzyme activities in rat serum levels
All serum enzymes of rats regularly injected with CCl4
were significantly increase compared with the normal
group. The silymarin group showed significant reduc-
tions in serum levels of GPT, GOT, and ALP. Serum
GPT activity was also significantly decreased by both
concentrations of EAAC, with both results were sig-
nificant (Fig. 3a; both p < 0.05). Serum GOT level was
significantly decreased in the EAAC 200 mg/kg group
(p < 0.01) but not in the 100 mg/kg group (Fig. 3b).
Serum ALP levels were markedly decreased by EAAC
200 mg/kg administration (Fig. 3c; p < 0.05).
Histological assessment of liver tissues
Livers were isolated from rats after sacrifice. H&E stain-
ing of liver sections of each group revealed severely
damage by CCl4 injection in tissue around the hepatic
vein (Fig. 4a). Silymarin treatment resulted in relatively
less necrosis and liver tissue collapse. Both concentra-
tions of EAAC ameliorated hepatic damage induced by
CCl4. Oil red O (ORO) staining of liver section is pre-
senting lipid accumulation caused by CCl4. The ORO
stain appeared in lesser portion of liver section in EAAC
200 mg/kg and silymarin groups compared with CCl4
group.
Reduction of lipid peroxidation
To investigate the effect of EAAC administration on
lipid peroxidation, a MDA assay was carried out with
liver tissue of each group. CCl4 injection induced the ac-
cumulation of lipid in liver, thus producing peroxidation
product (Fig. 5). Silymarin treatment significantly
reduced the products of lipid peroxidation. EAAC ad-
ministration decreased amount of lipid peroxidation
contents in liver tissue in a dose-dependent manner. Ad-
ministration of EAAC 200 mg/kg significantly decreased
MDA product (p < 0.01), but EAAC 100 mg/kg did not.
Table 1 Total phenolic, flavonoid and tannin contents and antioxidatn activity of different extract from Amomum cardamomum L
Extract TPC TFC TTC DPPH NBT
reduction
IC50 (μg/ml)
(mg GAE/g extract) (mg CE/g extract) (mg TAE/g extract) IC50 (μg/ml)
Aqua 7.59 ± 0.73 - 13.91 ± 2.43 - -
Ethanol 24.49 ± 0.13 0.42 ± 0.13 40.78 ± 0.94 249.77 ± 8.09 -
Ethyl acetate 72.32 ± 1.22 4.03 ± 0.05 51.52 ± 3.32 148.51 ± 6.51 21.35 ± 4.94
Buthanol 31.83 ± 0.20 0.42 ± 0.20 20.70 ± 6.31 211.05 ± 2.32 -
Dichloromethane 38.64 ± 1.17 1.62 ± 0.05 39.81 ± 1.46 163.31 ± 8.60 46.15 ± 5.55
Hexane 29.95 ± 1.12 3.75 ± 0.28 86.12 ± 3.09 224.33 ± 5.01 -
BHT - - - 34.78 ± 2.92 -
Ascorbic acid - - - - 22.02 ± 3.25
TPC total phenolic content, TFC total flavonoid content, TTC total tannin content, GAE gallic acid equivalent, CE catechin equivalent, TAE tannic acid equivalent
Fig. 1 Anti-oxidative activities of ethyl acetate fractions from Amomum cardamomum (EAAC) determined by hydroxyl radical assay. The result of
DNA nicking assay for hydroxyl radical scavanging activity was illuminated by checking DNA on gel electrophoresis. O.C Open cicular DNA nick
form, S.C Super coil plamid DNA
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Detoxification of CCl4-induced liver damage
As toxicity induced by CCl4 was attenuated by EAAC
administration, the concentration of liver detoxification
enzyme was investigated. The EAAC effect on total sulf-
hydryl (SH) and SOD activities was assessed (Figs. 6a
and b). CCl4 injection significantly reduced total SH and
SOD activities. Silymarin treatment successfully re-
covered both enzyme levels to almost the normal levels
(p < 0.05). However, there was a notable increase in both
total SH and SOD activities by both concentrations of
EAAC (p < 0.05). Gene expression levels of GST and
SOD in the liver were assessed with real-time quantita-
tive PCR. GST and SOD expression was suppressed by
CCl4 injection, but was significantly escalated in rats
treated with silymarin EAAC 200 mg/kg (Fig. 6c, d; p <
0.05).
Reduction of CYP2E1 expression levels
To investigate the mechanism related with the effect of
EAAC treatment, we performed real time quantitative
PCR. CCl4 injection increased CYP2E1 gene expression
by 101 % compared with the normal group. Silymarin
Fig. 2 Hepatoprotective effect of EAAC was assessed in vitro. a HepG2 Cell viability with different concentrations of EAAC was determined
after 24 h incubation. b Recovered HepG2 cell viability against CCl4 by treatment of different concentrations of EAAC and silymarin. The
culture media changed with FBS-free DMEM containing CCl4 (8 mM) for 2 h. * shows statistically significant differences at p < 0.05 from
the CCl4 group and ** at p < 0.01
Fig. 3 Effect of EAAC on various liver enzyme levels of serum from SD rat in vivo study. a GPT enzyme concentration, (b) GOT enzyme
concentration, (c) ALP enzyme concentration were represented as international unit (U/L). ## shows statistically significnat difference at p < 0.01
from the untreated group. * shows statistically significant differences at p < 0.05 from the CCl4 group and ** at p < 0.01
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treatment reduced this increment significantly (p < 0.01).
Treatment with EAAC 100 mg/kg produced no signifi-
cant difference, but whereas the 200 mg/kg concentra-
tion significantly reduced CYP2E1 expression (Fig. 7; p
< 0.01). This was also supported by similar result of con-
ventional PCR product loaded on agarose gel (Fig. 7,
upper panel).
Discussion
The data presented in this study demonstrate that A.
cardamomum protects against CCl4-induced acute
liver injury. CCl4 is an extensively studied hepatotoxin
that is converted CCl3 including trichloromethyl
(CCl3·, CCl3OO·) free radicals [15]. Free radical and
oxidative stresses have been associated with numerous
liver diseases, such as cirrhosis, genotoxicity of hep-
atic tissue, and hepatic carcinoma [1, 41]. Several en-
dogenous enzymatic and non-enzymatic systems are
needed to protect the liver from free radicals [42].
Natural plant-derived antioxidants protect cellular de-
toxification systems from the harmful responses of
excessive oxidation converted free radicals from CCl4
[20, 43].
The antioxidant properties of the A. cardamomum
ethanol extract and organic fractions were tested using
various in vitro systems. Especially, the ethyl acetate
fraction from A. cardamomum (EAAC) strongly inhib-
ited formation of DPPH free radicals, superoxide anions,
and hydroxyl radicals. The relatively high antioxidant
capacity was attributable to the abundance of polyphenol
and flavonoid compounds in ethyl acetate fraction from
crude extract of natural plants. Similarly, a recent study
[44] found that the ethyl acetate fraction of Crescentia
cuhete leaves and stem bark possess a stronger antioxi-
dant capacity than other fractions in a rapid in vitro
assay. It is clear that ethyl acetate fractions from natural
plants that contain phenolic compounds and flavonoids
have superior antioxidant properties. In addition, the
treatment of HepG2 hepatocarcinoma cells with CCl4
presently resulted in decreased cell viability. This obser-
vation agrees with previous reports using various cancer
cell lines [9, 45]. On the other hand, pretreatment with
EAAC significant recovered cell viability, perhaps due to
the reduction of cytotoxicity.
Various recent studies have demonstrated that natural
plant-derived phytochemicals protect the liver against
CCl4-induced damage, such as cirrhosis, steatosis, and
hepatic fibrosis [7, 20, 46]. This was presently implied by
the significant decreases in serum levels of ALT, AST,
Fig. 4 a. Hematoxylin-eosin (H&E) stained and (b). Oil Red O (ORO) stained sections of liver tissues from SD rat in vivo study. Normal group, CCl4
(1 mL/kg) treated group, Silymarin (50 mg/kg) + CCl4 treated group, EAAC (100 mg/kg) + CCl4 group and EAAC (200 mg/kg) + CCl4 group from
left to right. Pictures were taken by microscope under 200× magnification. Pictures show nearby area of central vein (arrow head)
Fig. 5 Effect of EAAC treatment on MDA levels in rat liver. Liver
tissue from each group was homogenized with 1.15 % KCl buffer
(9:1, w/w) and centrifuged. After centrifuged, supernatant was
collected to investigate MDA level. ## shows statistically significnat
difference at p < 0.01 from the untreated group. * shows statistically
significant differences at p < 0.05 from the CCl4 group and **
at p < 0.01
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Fig. 6 Effect of EAAC treatment on total SH levels, SOD activity and anti-oxidative mRNA gene levels in rat liver. Liver tissue was homogenized
and centrifuged. After centrifuged, supernatant was collected to investigate (a) total SH level and (b) SOD activity. For gene expression analysis,
liver tissue was homogenized and lysed with Trisure to isolate mRNA. After cDNA synthesized, real-time PCR was conducted to investigate mRNA
expression level. c GST expression level and (d) SOD expression level. ## shows statistically significnat difference at p < 0.01 from the untreated
group. * shows statistically significant differences at p < 0.05 from the CCl4 group and ** at p < 0.01
Fig. 7 Effect of EAAC treatment on CYP2E1 mRNA levels in rat liver. Liver tissue was homogenized and lysed with Trisure to isolate mRNA. After
cDNA synthesized, both conventional PCR and real-time PCR was conducted to investigate mRNA expression level. The result of conventional
PCR (CYP2E1 and GAPDH) was illuminated by gel electrophoresis. ## shows statistically significnat difference at p < 0.01 from the untreated group.
* shows statistically significant differences at p < 0.05 from the CCl4 group and ** at p < 0.01
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and ALP in liver tissue that displayed protection against
CCl4-induced degeneration. The decrease levels of these
serum enzymes correlates with fewer necrotic lesions or
histopathological injury, and lipid peroxidation in liver
tissue [12, 47]. Moreover, induction of phase II enzymes
including GSH, GST, and SOD are important in the bal-
ance between oxidative stress and antioxidation in a
CCl4-induced acute liver injury model [48]. The present
results show that exposure to CCl4 caused significant in-
creases in serum ALT, AST, and ALP due to hepatic
damage in rat liver. However, administration of 100 mg/
kg and 200 mg/kg body weight EAAC markedly restored
liver physiology, which might be due to the phenolic
compounds and total flavonoids. Furthermore, treatment
with EAAC increased several phase II enzymes including
total SH, GST, and SOD, which were reduced by CCl4,
likely due to the antioxidant properties of EAAC.
CYP2E1, the most important hepatic cytochrome P450
isoform, is a CCl4 converting enzyme that catalyzes pro-
duction of trichloromethyl free radicals in the liver [15,
49]. The liver is organ that is clearly influenced by
CYP2E1, therefore, downregulation of CYP2E1 was ex-
pected by decrease of trichloromethyl free radical forma-
tion and reduced liver damage, inducing hepatocyte
necrosis and hepatocellular injury [50]. In this study, the
treatment of rats with CCl4 led to a significant overex-
pression of the CYP2E1 gene compared to control rats.
However, treatment with 100 mg/kg and 200 mg/kg
body weight EAAC significantly reduced CYP2E1 pro-
duction. Therefore, it is suggested that A. cardamomum
has valuable therapeutic potential for liver disease
caused by CYP2E1 expression by decreasing CYP2E1 ex-
pression in liver.
Conclusion
The present study clearly demonstrates for the first time
the hepatoprotective effect of EAAC against CCl4-in-
duced acute liver injury. EAAC treatment significantly
alleviated oxidative damage and lipid oxidation through
its antioxidant properties. In addition, EAAC downregu-
lated CYP2E1 on hepatotoxic events, comparable to the
effect of silymarin in liver tissue. These findings suggest
that A. cardamomum could be therapeutic as a trad-
itional medicine in acute liver injury models.
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